<DOC>
	<DOC>NCT00804271</DOC>
	<brief_summary>To validate a new Alzheimer's Disease scale against other rating tools in subjects with dementia of Alzheimer's type, treated with memantine.</brief_summary>
	<brief_title>Memantine and Validation of a New Alzheimer's Disease Scale</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Diagnosis of probable Alzheimer's disease consistent with NINCDSADRDA criteria or with DSM IV TR criteria for Dementia of Alzheimer's type. Signed informed consent prior to the initiation of any study specific procedures. Sight and hearing (a hearing aid is permitted) are sufficiently good to allow the undertaking of studyrelated procedures and psychometric tests. Evidence of clinically significant and active pulmonary, gastrointestinal, renal, hepatic, endocrine or cardiovascular system disease. Intake of any medication that is contraindicated in combination with memantine. History of severe drug allergy, or hypersensitivity, or patients with known hypersensitivity to ingredients of memantine or lactose. Known or suspected history of alcoholism or drug abuse within the past 2 years. Current or previous treatment with memantine or participation in an investigational study with memantine.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>